Shiping P. Guo

Taiyuan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.

Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.

Journal: The New England journal of medicine
Published: July 08, 2026

Assessment of stapled vs handsewn anastomoses in video-assisted thoracoscopic and laparoscopic McKeown esophagectomy for esophageal cancer.

Assessment of stapled vs handsewn anastomoses in video-assisted thoracoscopic and laparoscopic McKeown esophagectomy for esophageal cancer.

Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Published: November 25, 2025

Three-field vs two-field lymphadenectomy in thoracic ESCC patients: a multicenter randomized study (NST 1503).

Three-field vs two-field lymphadenectomy in thoracic ESCC patients: a multicenter randomized study (NST 1503).

Journal: Journal of the National Cancer Center
Published: August 20, 2024

Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial.

Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial.

Journal: Nature medicine
Published: March 29, 2024

Benefits of camrelizumab plus carboplatin and albumin paclitaxel as induction therapy for locally advanced borderline resectable or unresectable esophageal squamous cell carcinoma.

Benefits of camrelizumab plus carboplatin and albumin paclitaxel as induction therapy for locally advanced borderline resectable or unresectable esophageal squamous cell carcinoma.

Journal: Thoracic cancer
Published: October 25, 2023

CT imaging indications correlate with the degree of lung adenocarcinoma infiltration.

CT imaging indications correlate with the degree of lung adenocarcinoma infiltration.

Journal: Frontiers in oncology
Published: November 26, 2022

Author Correction: Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma.

Author Correction: Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma.

Journal: Cell research
Published: February 18, 2022

Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma.

Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma.

Journal: Cancer cell
Published: February 07, 2022

Application of Anlotinib Combined With Neoadjuvant Chemotherapy in Primary EWS/PNET of Lung: A Case Report.

Application of Anlotinib Combined With Neoadjuvant Chemotherapy in Primary EWS/PNET of Lung: A Case Report.

Journal: Frontiers in oncology
Published: November 25, 2021

Primary EWS/PNET of the lung with TP53 germline and SKT11 somatic mutation: A case report and review of the literature.

Primary EWS/PNET of the lung with TP53 germline and SKT11 somatic mutation: A case report and review of the literature.

Journal: Thoracic cancer
Published: October 16, 2021

Expert consensus on resection of chest wall tumors and chest wall reconstruction.

Expert consensus on resection of chest wall tumors and chest wall reconstruction.

Journal: Translational lung cancer research
Published: September 18, 2021

Author Correction: Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma.

Author Correction: Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma.

Journal: Nature communications
Published: November 13, 2020
Showing 1-12 of 24

Last Updated: 09/26/2026